This concern is real but often overstated, particularly in people who are insulin sensitive or adapting to fat burning, and it becomes secondary to the muscle preservation imperative when semaglutide is involved
Choosing an unregulated source increases the risk of counterfeit medication or inappropriate dosing
However, retatrutide, as a multi-receptor agonist, may have broader effects on metabolism and potentially unique side effects as clinical trials continue to uncover its full profile
Malm-Erjeflt, M., Bjrnsdottir, I., Vanggaard, J., Helleberg, H., Larsen, U., Oosterhuis, B., Van Lier, J
Cardiovascular Drugs GLP-1 receptor agonists slow gastric emptying, which can delay the absorption of cardiovascular medications
Seizures are not listed among known adverse effects in the Summary of Product Characteristics or MHRA guidance